Skip to content

Krystal Biotech, Inc.

KRYS Nasdaq SEC CIK 1711279

Follow Krystal Biotech Weekly email: filings, results, news

News

4 stories filed under Krystal Biotech, grouped into ongoing threads

Krishnan sells

Thread · 3 stories

Krystal Biotech president, R&D Suma Krishnan sells $8.98m in stock

Markets 20 d ago

Krystal Biotech CEO Krish S. Krishnan sells $8.98m in company stock

Markets 20 d ago

Krystal Biotech (NASDAQ:KRYS) director Dino Rossi sells $8.2m shares

Markets 41 d ago 3 sources

More coverage

Krystal Biotech, Inc. 2026 Q2 - Results - Earnings Call Presentation

Earnings 50 d ago

Next results

NOV2

Q3 2026 results

Monday · estimated from the filing cadence

Profile

Headquarters: PITTSBURGH, PA, United States
Sector: Healthcare
Industry: Biological Products, (No Diagnostic Substances)

Peers

Where this page comes from

Profile · SEC EDGAR

Next results · estimated from the filing cadence (SEC EDGAR)

News · 4 stories clustered from the RSS aggregator